The trial studies the effects of semaglutide - a drug originally intended to reduce effects of diabetes focusing primarily on its effects on major heart disease and strokes versus that of diet and exercise or placebo
Participants receiving apitegromab preserved more lean mass than those receiving placebo while losing similar amounts of weight
Peel off the needle cover
RUO Disclaimer The products offered on this site are provided exclusively for in vitro studies
J Agric Food Chem 66:11911196 Pan H-Y, Ye Z-W, Zheng Q-W, Yun F, Tu M-Z, Hong W-G, Chen B-X, Guo L-Q, Lin J-F (2022) Ergothioneine exhibits longevity-extension effect in Drosophila melanogaster via regulation of cholinergic neurotransmission, tyrosine metabolism, and fatty acid oxidation
How much weight can a non-diabetic expect to lose on GLP-1 therapy